Inactive Instrument
Epigenomics AG Stock Deutsche Boerse AG
Stocks
DE000A0BVT96
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 22/07/25 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 763K 873K 706K 659K 1.24M 82.51M 1.25M 8.39M 3.26M 40.57M 3.28M 3.21M 141M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.73M 13.42M 10.85M 10.13M 19.01M 1.27B 19.15M 129M 50.17M 624M 50.4M 49.31M 2.17B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 01/03/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 01/06/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 05/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.82% | +8.22% | +101.55% | +100.72% | 4.28B | |
| -0.91% | -0.52% | +67.34% | +140.58% | 2.81B | |
| +2.98% | +6.34% | -23.28% | -38.76% | 2.01B | |
| +3.84% | +0.74% | +105.05% | -50.00% | 1.75B | |
| -4.32% | +4.03% | +31.57% | +215.49% | 1.35B | |
| -2.52% | -5.57% | -19.70% | +24.88% | 837M | |
| +0.96% | +5.85% | +154.85% | -60.82% | 767M | |
| -7.17% | -24.07% | +43.23% | - | 596M | |
| -1.44% | -6.93% | -31.75% | -16.94% | 508M | |
| Average | -1.04% | -1.03% | +47.65% | +39.39% | 1.66B | |
| Weighted average by Cap. | -0.37% | +2.59% | +61.36% | +64.09% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.47K 22.2K 20.72K 38.9K 2.6M 39.18K 264K 103K 1.28M 103K 101K 4.43M |
| Net income | -3.35M -3.84M -3.1M -2.89M -5.43M -363M -5.47M -36.84M -14.34M -178M -14.4M -14.09M -619M | -314K -359K -290K -271K -509K -33.96M -513K -3.45M -1.34M -16.7M -1.35M -1.32M -58M |
| Net Debt | 10.46M 11.96M 9.67M 9.03M 16.95M 1.13B 17.07M 115M 44.71M 556M 44.92M 43.95M 1.93B | 10.97M 12.55M 10.14M 9.47M 17.77M 1.19B 17.91M 121M 46.9M 583M 47.12M 46.1M 2.03B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
